Market Size of Mexico Bariatric Surgery Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2021 - 2022 |
| CAGR | 4.80 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Mexico Bariatric Surgery Market Analysis
The Mexican bariatric surgery market is poised to register a CAGR of 4.8% during the forecast period.
The pandemic affected the studied market. Various research studies provide insight into the pandemic's effect on the country's medical infrastructures. In July 2021, a research study published in the National Library of Medicine stated that surgeries were canceled or halted due to the pandemic, which adversely impacted market growth. However, the increasing medical tourism in the country is expected to increase market growth during the forecast period. For instance, according to the Mexican Council for the Medical Tourism Industry's data updated in January 2022, Mexico is a popular destination for healthcare tourism. As a result, more people travel to Mexico for treatment. As a result, the country continues to be one of the most popular tourist destinations. This also creates the opportunity for bariatric surgery. As the pandemic has subsided currently, the market has gained some traction, and thus the market is expected to have stable growth during the forecast period of the study.
The major contributors to the market growth are the increasing burden of chronic diseases, such as diabetes and heart disease. Heart disease is another factor in increasing the demand for bariatric surgery in the country. As per the American Heart Association 2022, 56.1% of adults in Mexico s have high levels of LDL-C, or bad cholesterol, which is thought to be the primary risk factor for cardiovascular disease. With financing from Novartis, the American Heart Association has begun a new implementation science program in Mexico, enhancing care for patients with ASCVD, often known as atherosclerosis. With this initiative, cardiology care in the country will increase in terms of prevention and treatment, ultimately boosting the demand for the studied market.
The "Mexican Social Security Institute (IMSS)" also shared plans to invest USD 677.2 million to build 111 new hospitals by 2024. This is expected to drive the studied market growth. These investments are predicted to provide infrastructure for surgeries in hospital and clinic settings, bolstering the overall market growth in the country. However, the high cost of these surgeries can hinder market growth.
